TipRanks
Go Ultimate55% OFF

Compare Relmada Therapeutics (RLMD) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
RLMDRelmada Therapeutics$3.58$381.88M-3.8954.31%Moderate BuyUnlock the RLMD analyst price target with TipRanks PremiumRLMDUnlock the RLMD top-analyst price target with TipRanks Premium
XBITXBiotech$1.88$57.32M-1.27-21.67%―Unlock the XBIT analyst price target with TipRanks PremiumRLMD vs XBITUnlock the XBIT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.88$309.64M-4.91147.13%Moderate BuyUnlock the PRLD analyst price target with TipRanks PremiumRLMD vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium
SPRBSpruce Biosciences$46.39$133.33M-1.14-56.75%Strong BuyUnlock the SPRB analyst price target with TipRanks PremiumRLMD vs SPRBUnlock the SPRB top-analyst price target with TipRanks Premium
HOWLWerewolf Therapeutics$0.99$47.92M-1.34-29.57%―Unlock the HOWL analyst price target with TipRanks PremiumRLMD vs HOWLUnlock the HOWL top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
RLMDRelmada Therapeutics3.581.3862.73%
XBITXBiotech1.88-0.41-17.90%
PRLDPrelude Therapeutics3.88-0.10-2.51%
SPRBSpruce Biosciences46.39-58.36-55.71%
HOWLWerewolf Therapeutics0.99-0.32-24.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts